[Physiopathological basis of thrombolytic therapy]. 1971

A G Dettori

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

A G Dettori
June 1990, Klinicheskaia meditsina,
A G Dettori
January 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
A G Dettori
March 1978, Minerva medica,
A G Dettori
September 1955, Revista medica cubana,
A G Dettori
January 1976, Voprosy okhrany materinstva i detstva,
A G Dettori
October 1975, La Revue du praticien,
A G Dettori
October 1973, Der Internist,
A G Dettori
July 1995, Thrombosis and haemostasis,
Copied contents to your clipboard!